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Cumulative patient effective dose and acute
radiation-induced chromosomal DNA damage
in children with congenital heart disease
Lamia Ait-Ali,1,2 Maria Grazia Andreassi,1,2 Ilenia Foffa,1,2 Isabella Spadoni,2
Eliseo Vano,3 Eugenio Picano1
ABSTRACT
Background The seventh Committee on “Biological
Effects of Ionizing Radiation” (BEIR VII, 2006) underlines
“the need of studies of infants who are exposed to
diagnostic radiation because catheters have been placed
in their hearts”.
Objective To determine the lifetime attributable risk
(LAR) of cancer associated with the estimated
cumulative radiological dose in 59 children (42 male, age
2.863.2 years) with complex congenital heart disease,
and to assess chromosomal DNA damage after cardiac
catheterisation procedures.
Methods In all patients, the cumulative exposure was
estimated as effective dose in milliSievert (mSv), and
LAR cancer was determined from the BEIR VII report. In
a subset of 18 patients (13 male, age 5.265.7 years)
micronucleus as a biomarker of DNA damage and long-
term risk predictor of cancer was assayed before and 2 h
after catheterisation procedures. Doseearea product
(Gy cm2) was assessed as a measure of patient dose.
Results The median life time cumulative effective dose
was 7.7 mSv per patient (range 4.6e41.2). Cardiac
catheterisation procedures and CT were responsible for
95% of the total effective dose. For a 1-year-old child, the
LAR cancer was 1 in 382 (25th to 75th centiles: 1 in 531
to 1 in 187) and 1 in 156 (25th to 75th centiles: 1 in 239
to 1 in 83) for male and female patients, respectively.
Median micronucleus values increased significantly after
the procedure in comparison with baseline (before 6& vs
after 9&, p¼0.02). The median doseearea product
value was 20 Gy cm2 (range 1e277).
Conclusion Children with congenital heart disease are
exposed to a significant cumulative dose. Indirect cancer
risk estimations and direct DNA data both emphasise the
need for strict radiation dose optimisation in children.
INTRODUCTION
Radiation can be used effectively for diagnosis and
treatment, but it can also subsequently cause cancers
and other conditions.1 Trends indicate that world-
wide population exposure from medical radiation is
increasing2 3 and the use of procedures with a high
radiation dose continues to grow steadily,4e8 espe-
cially in cardiology6 8dand particularly in paediatric
cardiology.9 Children are at least four times more
sensitive than adults to the induction of cancer, and
the proliferation of appropriate and inappropriate
examinations with high radiological dose in children
has raised concern among the paediatric commu-
nity10 and regulatory bodies.11 12 The National
Academies’ Biological Effects of Ionizing Radiation,
7th Report (BEIR VII, phase 2), presented to the
USA Congress in June 2005 and published in 2006,
underlines “the need of studies of infants who are exposed
to diagnostic radiation because catheters have been placed
in their hearts” among priority research needs.12
The BEIR VII report develops risk estimates for
cancer from exposure to low-level ionising radiation
using the most current data and epidemiological
models available, providing a framework for esti-
mating cancer risk associated with radiation expo-
sure from medical exposure.12
The aim of our study was to determine the life-
time attributable risk of cancer (fatal and non-fatal)
associated with the estimated lifetime cumulative
radiological dose in children with complex
congenital heart disease (CHD) by using the BEIR
VII estimates.
Since these data provide only indirect population-
based estimates, we also evaluated directly whether
radiation exposure during cardiac catheterisation
procedures can induce chromosomal DNA damage.
To this end, a micronucleus assay (MN) was
performed as a biomarker of chromosomal damage
and intermediate end point of carcinogenesis13 14
before and after radiation exposure.
PATIENTS AND METHODS
Patients
The patient population included 59 consecutive
inpatients with complex CHD (42 male,
age¼2.863.2 years) who were admitted in 2007 for
cardiac haemodynamic procedures to the G Pasqui-
nucci Hospital in Massa, Italy. Exclusion criteria
included the inability to obtain consent from the
child’s parents, and the impossibility of recon-
structing an accurate history for both the type and
number of radiological procedures.
Thirty-one interventional procedures were
performed (10 atrioseptostomy according to Rash-
kind, two pulmonary branch balloon angioplasties,
seven pulmonary valvuloplasties, two aortic
valvuloplasties, three patent ductus arteriosus
closures, one ventricular septal defect closure, six
aortic coarctation balloon angioplasties).
In all patients, a detailed radiological history was
also reconstructed. All available paper and electronic
records of present and past hospital admissions were
analysed usingdas the primary source of informa-
tiondthe electronic data bank of our institute.
All past examinations performed outside our
institute were recalled by interviewing the patients’
parents at the time of admission and by direct
perusal of available medical records of the patient.
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Examinations without an available record were not considered.
Demographic and clinical characteristics of the studied patients
are summarised in table 1. Legal representatives of patients gave
their informed consent at the time of admission to grant the use
of hospital data for research purposes and specifically for the
bioassay study, authorised by the local ethical research
committee.
Indirect estimation of cumulative dose and cancer risk for
radiation exposure
For each examination the estimated effective dose in milliSievert
(mSv) was derived from average dose values reported by the
peer-reviewed literature on effective dose for paediatric ionising
procedures2 .15e19
Representative values and ranges of the effective radiation
dose for some diagnostic radiology procedures are presented in
table 2.
In order to calculate the cumulative risk of cancer, we used
estimates of cancer from BEIR VII released in 2006.12
According to these estimates, it is predicted that for a 10 mSv
effective dose in adult approximately one person in 2000 would
develop fatal cancer11 and one in 1000 would develop fatal and
non-fatal cancer.12 The BEIRVII report estimates that the cancer
risk in children is higher than for adults. For instance, the same
radiation in the first years of life for boys produces three to
four times the cancer risk as exposure between the ages of 20
and 50.12
Direct dose estimation and MN assay
The MN cytokinesis block assay in human lymphocytes was
performed on a randomly selected subset of 18 patients (13 male,
age 5.265.7 years) without comorbidity, and who had undergone
cardiac catheterisation procedures for diagnostic purposes (n¼13)
and for therapeutic procedures (n¼5).
All procedures were performed using the Philips Integris
H5000C monoplane with the x-ray tube MRC 200 0508 ROT
GS 1001. The doseearea product (DAP) was obtained from
a transmission ionisation chamber built into the collimator
housing of the radiography tube. The DAP (Gy cm2) is a quan-
tity used to estimate patient doses in fluoroscopy guided proce-
dures and represents the dose in air measured at a given distance
from the x-ray tube multiplied by the area of the x-ray beam at
that distance.15 20 21
The cumulative DAP for a procedure is a surrogate measure-
ment for the total amount of x-ray energy delivered to the
patient, and is considered a valid indicator of a patient’s dose
and consequent risk for radiation-induced effects. Effective dose
was also estimated by the use of a conversion factor (1.2 mSv
Gy1 cm2) derived from the literature (CF¼effective dose/DAP
(mSv Gycm2)).17
Venous blood samples were collected at baseline and 2 h after
the procedure. Two separate cultures from each sample were set
up by mixing 0.3 ml of whole blood with 4.7 ml of RPMI 1640
medium; cultures were incubated at 378C for 72 h. Cytochalasin
B (6 mg/ml) was added 44 h after culture initiation. Cells were
then harvested and fixed according to the standard method in use
in our laboratory.14 For each sample, 1000 binucleated cells were
scored by use of an optical microscope (final magnification3400)
for MN analysis, according to the criteria for MN acceptance.22
We quantified the micronucleated binucleated cell frequency as
the number of micronucleated cells per 1000 cells. MN frequency
was evaluated by the same three microscopists who had no
information as to the identity of patients.
Statistical analysis
Statistical analyses of the data were conducted with the Stat
view statistical package, version 5.0.1. The average dose values
of individual examinations were expressed as median and
25the75th centiles. Differences were evaluated by the
ManneWhitney U test. Because of the skewness of the distri-
butions of MN values, analyses were performed using the loga-
rithmic transformation of data. Results are expressed as mean
(6SD). Differences between the means of the two continuous
variables were evaluated by the paired Student t test. Regression
analysis with the Pearson test was also used to evaluate the
relationship between the two continuous variables. A p value
<0.05 was considered significant.
RESULTS
In total, 1548 procedures with ionising radiation were performed
during the lifetime of the 59 patients.
On average, each patient underwent a mean of 26.2626.3
examinations (range 1e150, 25the75th interquartile range
12e27.7). The number of each type of examinations is given in
table 3. The median life time cumulative effective dose was
7.7 mSv per patient (range 4.6e41.2, 25the75th centiles
5.5e12.3). The estimated median effective dose was not signifi-
cantly different between male (7.1 mSv, 25the75th centiles
5.1e12.5 mSv) and female (9.4 mSv, 25the75th centiles
6.5e18.1 mSv) patients. A positive significant correlation was
found between cumulative radiological effective dose and age
(r¼0.518, p<0.0001).
Table 1 Demographic and clinical characteristics of the study
population
Variable Value
Age, mean6SD, years (range) 2.863.2
(1 monthe16 years)
Gender, n
Male/female 42/17
BMI, kg/m2 (range) 11.5615 (2.1e75)
Diagnosis, n
Transposition of the great arteries (6 ventricular septal
defect)
12
Coarctation of the aorta (6ventricular septal defect) 8
Tetralogy of Fallot 7
Pulmonary stenosis 6
Functionally univentricular heart 5
Pulmonary atresia (6 ventricular septal defect) 4
Patent ductus arteriosus 3
Other complex CHD 14
CHD, congenital heart disease.
Table 2 Representative effective radiation dose, range and equivalent
number of plain chest radiographs for paediatric cardiac procedures
Examination
Effective dose,
mSv (range)
Chest x-rays
(range)
Conventional radiology
Chest x-ray (single posteroanterior) 0.02 1
CT
Head CT 4 (1e6) 200 (50e300)
Chest CT 3 (5e12) 150 (250e600)
Abdomen CT 5 (4e20) 250 (200e1000)
Interventional cardiology
Diagnostic catheterisation 4.6 (0.6e23) 230 (30e1150)
Therapeutic catheterisation 6 (1e37) 300 (50e1850)
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Figure 1 shows the contribution of various types of medical
ionising procedures to the total collective dose. Conventional
x-ray examinations represent 93% of the total number of
examinations, corresponding to only 5% of the collective effec-
tive dose. Three types of procedures were responsible for about
95% of the total collective effective dose: diagnostic catheter-
isation, interventional catheterisation and CT.
The corresponding estimated lifetime attributable risk of fatal
cancer for all combinations of age (ranging from 0to 15 years)
was 1 in 1717 and 1 in 859, for male (receiving 7.1 mSv) and
female (receiving 9.4 mSv) patients, respectively.
The lifetime attributable risk (fatal and non-fatal cancer) was
1 in 804 for male subjects, and 1 in 331 for female subjects.
However, risks were 1.9e2 times higher for child of 1 year than
for a 15 year old.
For a 1-year-old child, the median risk of (fatal and non-fatal)
cancer was 1 in 382 (25th to 75th centiles 1 in 531 to 1 in 187)
and 1 in 156 (25th to 75th centiles 1 in 239 to 1 in 83) for male
and female patients, respectively.
For direct dose estimation in the subset of 18 patients, the
median fluoroscopy time during the cardiac catheterisations was
22.8 min (range 3e34) without any significant difference between
diagnostic and interventional procedures (p¼0.6). The mean DAP
value was 45.3664.8 Gy cm2 with a median of 20 Gy cm2 and
a 25the75th interquartile range of 12e64 Gy cm2.
Median effective DAP values were found to be significantly
higher in therapeutic interventions than in diagnostic procedures
(93 Gy cm2 vs 14 Gy cm2, p¼0.005). DAP values for all patients
studied are presented in table 4. The highest value of DAP dose
delivered was found for an interventional procedure involving
one aortic coarctation balloon angioplasty (277 Gy cm2).
The median effective MN value was 6& (25the75th inter-
quartile range 4e7&) at baseline and showed a significant rise at
2 h with amedian of 9& (25the75th interquartile range 8e11&)
after procedures (Figure 2). Median MN values were higher than
the baseline values for both diagnostic (7& vs 11&, p¼0.02) and
therapeutic cardiac catheterisation procedures (5& vs 9&,
p¼0.03). However, we did not observe any relationship between
DAP and % MN increase (r¼0.1, p¼0.74), even after taking into
account the patient’s weight (r¼0.1, p¼0.6).
DISCUSSION
The average present-day child with CHD is exposed to a signif-
icant cumulative radiological effective dose. The new generation
of patients with CHD benefits from the enormous advances in
cardiac imaging and interventional cardiology, but also receives
an unprecedented radiological exposure, associated with
a significant long-term risk of cancer based on the latest risk
estimates.
The rise of imaging testing in children
We are witnessing a spectacular rise in the potential and versa-
tility of cardiovascular imaging in children. The use of multislice
CT is increasing even faster in children than in adults, presum-
ably because of the big advantage of a short exposure time that
allows for its use without a sedative.3 It is estimated that there
were at least 6.5 million CT examinations in the USA in the
paediatric age band in the year 2006, corresponding with about
15% of all CTexaminations.5 Nuclear cardiology stress testing in
children is performed in 30% of US institutions, according to
a recent survey of the AHA-ACC.23 The Spanish Society of
Cardiology has published data on paediatric cardiology24
showing increases in the number of fluoroscopic procedures over
the years 2000e4 of between 21% (for dilatation) to 97% (for
embolisations).
Table 3 Typical effective dose from paediatric and cardiology
procedures
Examination Total number
Number per patient,
mean (range)
Conventional radiology
Chest x-ray 1432 25.1625.7 (1e144)
CT
Head CT 7 1.060.6 (0e2)
Chest CT 7 1.260.4 (1e2)
Interventional cardiology
Diagnostic catheterisation 55 1.360.6 (1e3)
Therapeutic catheterisation 40 1.260.6 (1e4)
Figure 1 The most frequent examinations and total
collective dose in congenital heart disease: relative
contribution of conventional radiographs, CT, diagnostic
catheterisation and interventional radiology to (A) the
frequency and (B) the total collective effective dose.
1%
2.5%
3.5%
93% 41%
43%
11%
5%
X-rays
Diagnostic cath
Interventional cath
Computed Tomography
A
Frequency of examinations
B
Total collective dose
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Catheterisation procedures in children are typically more time
consuming than adult procedures.18 For several reasons, proce-
dures are longer in children, especially infants, because many
patients have had previous studies and have limited access site; in
infants the vessels are smaller and more difficult to cannulate;
multiple angiograms in several cardiac chambers, using different
views, are often needed.
Special problems of medical radiation in children
The growing use of interventional and non-invasive imaging
with ionising radiation in children represents a tremendous
benefit for the diagnosis and treatment of small patients.
However, there are special problems in children that one may
wish to consider. First, for any given dose children are three-to-
four times more sensitive than adults to the induction of
cancer as they have more rapidly dividing cells than adults and
have longer life expectancy.1 3 11 12 Second, for a given procedure,
the effective dose is larger in a small infant than in an adult:
organs are closer together in small children, resulting in more
radiation dose to nearby organs when the area of interest is being
imaged.1 11 12 Third, in paediatric cardiology, radiological proce-
dures are practised and/or prescribed by cardiologists, who may
sometimes have suboptimal awareness of doses and risks25 owing
to lack of adequate formal radiation training26dalthough it is
also true that even radiologists may substantially underestimate
radiation doses and risks.27 Fourth, cardiological examinations
deliver the highest organ dose from CTand interventions28 29 to
lung and breast. In particular, during a cardiac CT the breast dose
is about 10 times higher than with cardiac interventional
procedures. Recent ICRP 2007 documents30 left virtually
unchanged the whole-body risk estimates, but raised the breast
risk factor (ie, the excess probability of fatal cancer) by 210%,
from 40 in 1 000 000 per mSv in ICRP 1991 to 124 in 1 000 000 per
mSv in ICRP 2007.30 The same document also raised, albeit less
markedly, the lung risk factor by 33%, from 85 to 113 in 1 000 000
per mSv. Although these estimates are clouded by a certain degree
of uncertainty in the low-dose range, the epidemiological data31
in children exposed to medical radiation corroborate the
assumption of all major organisations that even low doses can
harm the patient, and no safe dose exists.12
Comparison with previous radiological and biodosimetric studies
In our patients the main contribution to dose was from inter-
ventional procedures and CT (84% and 11% of the average dose,
respectively). This picture is broadly consistent with recent data
on sources of irradiation for the “average” (non-cardiological)
patient5 and on adult cardiological patients.32 Our data are also in
agreement with the preliminary data presented by the European
Heart Survey, which reported an annual effective dose of
0.46 mSv/year in the follow-up of these patients, with about
80% of the dose coming from CTand angiography.33
Chromosome aberrations in circulating lymphocytes are an
intermediate end point of carcinogenesis and a long-term
predictor of cancer,13 14 and increased a few hours after a fluoro-
scopic cardiac procedure in children was reported, in a pioneering
study conducted in 1978 by Adams et al.34 Young adolescents
with repaired CHD who were exposed to low-dose diagnostic
ionising radiation at age <1 year, have an up to threefold increase
in chromosomal aberrations in circulating lymphocytes decades
after the exposure.14 In our study, the indirect population-based
estimates of cumulative dose and cancer risk were corroborated
by direct measurements of MN increase in a subset of patients.
The increase was obvious and consistent, although with
substantial variability probably owing to genetic differences in
polymorphisms of genes involved in DNA damage and/or repair
and an environmental oxidanteantioxidant milieu.35 This
approach provides a direct documentation of radiation genotox-
icity and may clear the pathway to individually tailored radia-
tion-sparing or chemopreventive strategies.
Study limitations
The number of patients is relatively small, but they are
consecutive and representative of the spectrum of clinical situ-
ations met in a contemporary paediatric cardiology and cardiac
surgery. An undoubted limitation of our study is that the life-
time radiological history was derived from hospital records,
when available, and from patient history. This leads unavoidably
to an approximation, and possibly to an underestimation, of the
total radiological burden.
Another limitation is that there is in the real world a marked
variability in the dose of each examination.36 This variability is
highest for interventional procedures. For instance, a percuta-
neous procedure of closure of patent ductus arteriosus is associ-
ated with an average effective dose corresponding to 7.6 mSv, but
the individual procedure value may range between 2.1 and
Table 4 Patient dose for diagnostic and therapeutic catheterisation
procedures7
Type of procedure Gender
Age,
months
Weight,
kg
Fluoroscopy
time, min
DAP
Gy cm2
Diagnostic M 5 4.9 30 7
Stent implantation M 168 57.0 25 277
Diagnostic F 36 12.4 26 20
Diagnostic F 1 2.9 23 6
Diagnostic M 6 9.4 3 1
Balloon valvuloplasty M 4 4.2 24 12
Diagnostic M 8 6.7 34 14
Stent implantation F 168 58.0 19 64
Stent implantation F 192 75.0 13 99
Diagnostic M 96 23.8 17 20
Diagnostic M 132 37.0 30 65
Diagnostic M 24 12.5 20 14
Diagnostic M 6 5.0 27 12
Stent implantation M 120 27.7 26 93
Diagnostic F 48 29.0 19 35
Diagnostic M 8 7.0 25 14
Diagnostic M 96 25.2 28 35
Diagnostic M 5 6.0 21 28
DAP, dose-area product.
M
N
 ‰
0
5
10
15
20
25
Baseline 2 hrs
p=0.02
Figure 2 Box-and-whiskers plot of micronuclei number before and 2 h
after radiation exposure in the overall population. Median and 25e75th
centiles are shown for each group. Values above the 90th centile and
below the 10th centile (outliers) have been separately plotted (as circles).
MN, micronucleus.
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36 mSv4 37 38 Both these aspectsdthe recall bias and the adop-
tion of typical dose values from the literature rather than true
measured valuesdmight have affected the precision of individual
patient dose estimation, but are unlikely to substantially affect
the order of magnitude of observed values. In addition, we inte-
grated the history-based approach, based upon indirect assess-
ment of doses and population-based estimates of risks, with
a direct, patient-based, individual assessment of patient dose and
of acute radiation damage through direct biodosimetry with MN
assay and faithful radiation dose measurement with DAP. The
two approaches are conceptually complementary and seem to
point in the same direction, indicating that potentially oncogenic
radiation-induced damage is not negligible in these children.
Clinical implications: justify and optimise
Although the benefits of imaging are immense, it is also possible
that not all these examinations are entirely appropriate and that
there is a suboptimal management of radiological doses (and
long-term cancer risks) in everyday clinical practice of paediatric
cardiology. The radiation concern is particularly important in
our patients with CHD for three reasons. First, adult grown-up
patients with surgically repaired CHD are a large and growing
population, estimated to be one million in US in the year 2000,
compared with an estimated 300 000 in 1980, and 1.4 million are
expected by 2020.39 Second, the long-term outcome of the
underlying cardiac disease has been dramatically improved by
interventions in the past decade, and now excellent long-term
survival is the rule, rather than the exception.9 10 Third, and most
importantly, children are several times more sensitive to radia-
tion than middle-aged adults.1 3 11 12 Therefore, when managing
today a serious condition such as a complex CHD, we have also
to protect the patient from risks that may become clinically
manifest after years and even decades. We should justify the
indication and optimise the dose delivery, adjusting doses,
reducing multiple scans with contrast material and eliminating
inappropriate referrals.
For instance, the application of currently available dose-
reduction techniques for heart scan and invasive cardiology
could be strongly applied in daily practice in order to allow
a reduction of patient doses while maintaining the image
quality.40 41 These practice patterns were recommended by the
FDA, the European Union referral guidelines for imaging and by
the recent white paper of the American College of Radiology.42 In
Europe the justification, optimisation and responsibility princi-
ples are also reinforced by the Euratom law.43 The challenge
ahead is to implement these recommendations universally in
clinical practice.
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